| Not Yet Recruiting | A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （NEZHA-2） Chronic Rhinosinusitis With Nasal Polyposis | Phase 2 | 2026-05-31 |
| Recruiting | Study of CM383 in Healthy Subjects Healthy | Phase 1 | 2026-01-01 |
| Recruiting | A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis. Atopic Dermatitis (AD) | Phase 2 | 2025-12-01 |
| Recruiting | Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU) Chronic Spontaneous Urticaria (CSU) | Phase 2 | 2025-11-27 |
| Recruiting | A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia Autoimmune Cytopenia, Immune Thrombocytopenia (ITP), Autoimmune Hemolytic Anemia | Phase 1 / Phase 2 | 2025-11-18 |
| Recruiting | Study of CM559 in Healthy Subjects Healthy Subjects | Phase 1 | 2025-09-01 |
| Not Yet Recruiting | A Study of Stapokibatrt in Children Subjects With Atopic Dermatitis Atopic Dermatitis | Phase 3 | 2025-09-01 |
| Not Yet Recruiting | Study of CM336 in Relapsed or Refractory Multiple Myeloma Patients Multiple Myeloma (MM) | Phase 3 | 2025-09-01 |
| Not Yet Recruiting | Study of CM313 in Subject With IgA Nephropathy IgA Nephropathy | Phase 2 | 2025-09-01 |
| Recruiting | Study of CM512 Injection in Subjects With Moderate-to-severe Asthma Asthma | Phase 2 | 2025-08-19 |
| Recruiting | Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain Amyloidosis Primary Light-Chain Amyloidosis | Phase 2 | 2025-07-25 |
| Recruiting | Study of CM518D1 in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 / Phase 2 | 2025-06-27 |
| Not Yet Recruiting | A Study of CM512 in Subjects With Moderate-to-Severe Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease | Phase 2 | 2025-06-20 |
| Recruiting | Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis Atopic Dermatitis | Phase 2 | 2025-06-19 |
| Not Yet Recruiting | A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （NEZHA-1） Chronic Rhinosinusitis With Nasal Polyposis | Phase 2 | 2025-05-16 |
| Not Yet Recruiting | Study of Stapokibatrt in Children Subjects With Atopic Dermatitis Atopic Dermatitis | Phase 3 | 2025-05-01 |
| Recruiting | Study of CM313(SC) Injection in Subjects With Platelet Transfusion Refractoriness Platelet Transfusion Refractoriness | Phase 1 / Phase 2 | 2025-03-25 |
| Not Yet Recruiting | Study of CM313(SC) Injection in Subjects With Relapsed/Refractory Aplastic Anemia Aplastic Anemia | Phase 1 / Phase 2 | 2025-03-01 |
| Not Yet Recruiting | Study of CM313(SC) Injection in Systemic Lupus Erythematosus(SLE) Systemic Lupus Erythematosus | Phase 2 | 2025-02-01 |
| Active Not Recruiting | Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP) Primary Immune Thrombocytopenia | Phase 2 | 2024-11-11 |
| Recruiting | A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's D Alzheimer Disease | Phase 1 | 2024-11-08 |
| Recruiting | Study of Stapokibart Injection in Patients With Allergic Rhinitis Allergic Rhinitis | Phase 2 | 2024-09-30 |
| Completed | Study of CM512 in Healthy Subjects and Patients With Atopic Dermatitis Atopic Dermatitis | Phase 1 | 2024-09-02 |
| Active Not Recruiting | Study of CM310 in Adolescent Subjects With Atopic Dermatis Atopic Dermatitis | Phase 3 | 2024-08-02 |
| Not Yet Recruiting | Study of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis Chronic Rhinosinusitis With Nasal Polyps | Phase 2 | 2024-06-30 |
| Active Not Recruiting | Study on the Treatment of Prurigo Nodularis With Stapokibart Injection Prurigo Nodularis | Phase 3 | 2024-06-25 |
| Recruiting | Single Dose Escalation Study of CM383 in Healthy Volunteers Alzheimer Disease | Phase 1 | 2024-05-28 |
| Unknown | Study Evaluating the Pharmacokinetics of CM310 in Healthy Subjects Healthy | Phase 1 | 2024-04-30 |
| Unknown | Study of CM310 in Subjects With Seasonal Allergic Rhinitis Seasonal Allergic Rhinitis | Phase 2 | 2024-03-30 |
| Unknown | A Study of CM310 in Subjects With Moderate-to-Severe Atopic Dermatitis Atopic Dermatitis | Phase 2 | 2024-03-30 |
| Completed | Study of CM310 Injection in Adolescent Subjects With Atopic Dermatis Atopic Dermatitis | Phase 3 | 2024-03-21 |
| Unknown | Study of CM313 in Healthy Subjects Healthy | Phase 1 | 2024-03-12 |
| Unknown | A Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma Multiple Myeloma | Phase 1 / Phase 2 | 2024-02-28 |
| Completed | Study of CM310 in Children Subjects With Moderate-to-severe Atopic Dermatis Atopic Dermatitis | Phase 1 / Phase 2 | 2023-12-22 |
| Completed | Study of CM310 in Patients With Allergic Rhinitis Allergic Rhinitis | Phase 2 | 2023-08-23 |
| Completed | Study of CM310 in Subjects With Allergic Rhinitis Allergic Rhinitis | Phase 3 | 2023-08-10 |
| Recruiting | Clinical Study of CM338 in the Treatment of Immunoglobulin A Nephropathy IgA Nephropathy | Phase 2 | 2023-05-08 |
| Completed | Study to Evaluate Pharmacokinetics, Safety and Efficacy of CM310 Healthy | Phase 1 | 2023-03-22 |
| Completed | Study of CM326 Injection in Healthy Subjects Healthy | Phase 1 | 2023-03-21 |
| Completed | Study of CM310 Injection in Subjects With Moderate-to-Severe Atopic Dermatitis Atopic Dermatitis | Phase 2 | 2023-03-10 |
| Unknown | The Study of CM326 in Adult Subjects With Atopic Dermatitis Atopic Dermatitis | Phase 2 | 2023-02-09 |
| Unknown | The Study of CM326 in Moderate-to-severe Atopic Dermatitis Moderate-to-severe Atopic Dermatitis | Phase 2 | 2022-12-27 |
| Unknown | A Study of CM313 Injection in Subjects With Systemic Lupus Erythematosus Systemic Lupus Erythematosus | Phase 1 / Phase 2 | 2022-10-30 |
| Completed | A Study of CM310 in Children Patients With Moderate-to-severe Atopic Dermatis Atopic Dermatitis | Phase 2 | 2022-10-07 |
| Unknown | A Study of CM310 in Subjects With Chronic Pruritus Chronic Pruritus of Unknown Origin | Phase 2 | 2022-08-30 |
| Completed | A Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （CROWNS-2） Chronic Rhinosinusitis With Nasal Polyposis | Phase 3 | 2022-08-09 |
| Recruiting | A Study of CM336 in Patients With Relapsed or Refractory Multiple Myeloma Multiple Myeloma | Phase 1 / Phase 2 | 2022-08-09 |
| Completed | A Study of CM326 in Patients With Chronic Rhinosinusitis With Nasal Polyps Chronic Rhinosinusitis With Nasal Polyps | Phase 1 / Phase 2 | 2022-07-11 |
| Completed | Multiple Ascending Dose Study of CM338 in Healthy Volunteers Healthy Subjects | Phase 1 | 2022-05-24 |
| Completed | A Study of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis Atopic Dermatitis | Phase 3 | 2022-04-22 |
| Recruiting | A Study of CM350 in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 / Phase 2 | 2022-04-21 |
| Unknown | The Study of CM326 in Patients With Moderate-to-severe Atopic Dermatitis Moderate-to-severe Atopic Dermatitis | Phase 1 / Phase 2 | 2022-02-17 |
| Completed | A Study of CM310 in Subjects With Moderate to Severe Asthma Asthma | Phase 2 | 2022-01-12 |
| Completed | A Multiple Ascending Doses Study of CM326 Injection in Healthy Subjects Asthma | Phase 1 | 2022-01-07 |
| Completed | Single Ascending Dose Study of CM338 in Healthy Volunteers Healthy | Phase 1 | 2021-12-11 |
| Completed | The Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyps Chronic Rhinosinusitis With Nasal Polyps | Phase 2 | 2021-11-30 |
| Completed | The Study of CM310 in Patients With Atopic Dermatitis Moderate-to-severe Atopic Dermatitis | Phase 2 | 2021-06-07 |
| Unknown | Dose Escalation and Expansion Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma and Lymp Multiple Myeloma, Lymphoma | Phase 1 | 2021-04-26 |
| Completed | Single Ascending Dose Study of CM326 in Healthy Volunteers Asthma | Phase 1 | 2021-04-13 |
| Completed | Subcutaneously CM310/Placebo in Patients With Chronic Rhinosinusitis With Nasal Polyposis (CROWNS-1) Chronic Rhinosinusitis (Diagnosis), Nasal Polyps | Phase 2 | 2021-04-06 |
| Completed | Subcutaneously CM310/Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD) Moderate-to-severe Atopic Dermatitis | Phase 2 | 2021-02-24 |
| Completed | Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901 Advanced Solid Tumor, Gastric Cancer(Including Gastroesophageal Junction Adenocarcinoma), Pancreatic Cancer | Phase 1 | 2020-12-24 |
| Completed | Dose Escalation Trial of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis (AD) Moderate-to-severe Atopic Dermatitis | Phase 1 / Phase 2 | 2020-07-21 |
| Completed | Study of CM310 in Healthy Subjects Healthy | Phase 1 | 2019-09-03 |